The barcode project: a strategy to track the early naïve reservoir
条形码项目:追踪早期幼稚水库的策略
基本信息
- 批准号:10762820
- 负责人:
- 金额:$ 82.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAntigensBar CodesCD4 Positive T LymphocytesCD8B1 geneCellsCessation of lifeChronicClonalityCoculture TechniquesCohort AnalysisDataEarly treatmentExonsExposure toFailureFrequenciesFutureGoalsHIVHalf-LifeIndividualInfectionInfectious AgentInflammatoryLinkMaintenanceMeasurementMeasuresMemoryMethodsModelingPhenotypePlayPopulationPositioning AttributePre-Clinical ModelPreclinical TestingProliferatingPropertyProvirus IntegrationProvirusesResistanceRoleSample SizeSamplingSystemT memory cellT-LymphocyteT-Lymphocyte SubsetsTestingTropismViralVirusWorkcohortdesignexperienceexperimental studyimmune clearancein vivoinnovationinsightintegration sitemathematical modelmemory CD4 T lymphocytenovelnovel strategiespharmacologicresponsetime use
项目摘要
Memory CD4+ T cells are believed to be the primary reservoir for HIV; however, emerging evidence suggests
an important role for naïve CD4+ T cells. Specifically, sequencing studies suggest the naïve reservoir
contributes substantially to the intact HIV reservoir in chronic progressors, but is practically absent in elite
controllers. While the naïve reservoir is small, it may have outsized effects on the overall reservoir since we
find the naïve reservoir repopulates the memory based on preliminary clone tracking studies. Objective: The
long-term goal is to dissect the role of the naïve reservoir on the overall reservoir in acutely infected individuals
and in a primary model of latency. We will first determine the extent and frequency of naïve infection in acutely
treated individuals. The naïve reservoir has been understudied in this population, but as early ART initiation
becomes more frequent, it is essential to understand the consequences on the overall reservoir. We
hypothesize that the naïve reservoir may be a good predictor of overall reservoir decay. Premise: Underlying
this hypothesis is the idea that the naïve reservoir has a unique ability to provide a long-lived relatively safe
harbor for proviruses due to their relative resistance to immune clearance, while the memory reservoir is more
prone to express HIV and to experience CD8 clearance. Aims: We will determine the contribution of infected
naïve T cells to reservoir dynamics in acutely treated individuals (Aim1) and present a novel ex vivo model to
test the underlying hypothesis behind the mechanism of naïve's contribution (Aim2). Design and Methods: In
both aims, we will measure reservoir size, diversity, clonality, proviral orientation and their dynamics over time
using proviral sequencing and a novel integration site sequencing. To avoid limiting dilution, we developed
methods utilizing Primer-ID to link barcoded proviral sequences to their integration sites. Our optimized model
with barcode tracking uniquely enables us to follow the fate of individual infected naïve T cells. This approach
reveals distinct properties of the naïve reservoir related to its reactivation potential as well as its response to
cognate antigen, LRAs and CD8s. A critical innovation of our model is the ability to track specific subsets under
various conditions that perturb the reservoir. In Aim3, we use the data generated from restricted infections
(Aim2) to dissect the role of naïve and memory infection using mathematical models and then compare the
effect of the naïve reservoir on HIV dynamics in acutely treated individuals from Aim1. We envision this work
will show that naïve infection is fundamental to a formidable reservoir and will ultimately provide a useful
preclinical model for evaluating mechanisms of persistence and future therapies. We will evaluate the effect of
various LRAs and CD8s on the naïve versus memory reservoir to provide a more thorough mechanistic
understanding of the naïve reservoir. These experiments will provide insights into the failure of latency reversal
and ultimately shed light on new approaches for targeting this reservoir in disguise.
记忆性CD4+ T细胞被认为是HIV的主要储存库;然而,新出现的证据表明
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Una T O'Doherty其他文献
Una T O'Doherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Una T O'Doherty', 18)}}的其他基金
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
- 批准号:
10358573 - 财政年份:2020
- 资助金额:
$ 82.89万 - 项目类别:
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
- 批准号:
10579911 - 财政年份:2020
- 资助金额:
$ 82.89万 - 项目类别:
Determinants of reservoir contraction and expansion in vivo, ex vivo, and in vitro
体内、离体和体外储库收缩和扩张的决定因素
- 批准号:
10022993 - 财政年份:2020
- 资助金额:
$ 82.89万 - 项目类别:
Unveiling the chromosomal address of intact HIV clones to provide insights into persistence
揭示完整 HIV 克隆的染色体地址,以提供对持久性的见解
- 批准号:
9790462 - 财政年份:2019
- 资助金额:
$ 82.89万 - 项目类别:
Unveiling the chromosomal address of intact HIV clones to provide insights into persistence
揭示完整 HIV 克隆的染色体地址,以提供对持久性的见解
- 批准号:
9889887 - 财政年份:2019
- 资助金额:
$ 82.89万 - 项目类别:
An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agents
预测抗储库药物结果和探讨机制的离体模型
- 批准号:
8930064 - 财政年份:2014
- 资助金额:
$ 82.89万 - 项目类别:
An ex vivo model to predict outcomes and probe mechanism of anti-reservoir agents
预测抗储库药物结果和探讨机制的离体模型
- 批准号:
8842406 - 财政年份:2014
- 资助金额:
$ 82.89万 - 项目类别:
Probing mechanisms of reduced HIV reservoirs in an interferon-a clinical trial
干扰素临床试验中探索减少 HIV 储存的机制
- 批准号:
8603530 - 财政年份:2013
- 资助金额:
$ 82.89万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 82.89万 - 项目类别:
Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 82.89万 - 项目类别: